Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Women news

Show

From To
Screening may miss pre-cancerous anal lesions in women with HIV

Existing algorithms to screen for anal cancer in women living with HIV could be missing many cases of anal high-grade squamous intraepithelial lesions (HSIL) – abnormal tissue

Published
12 March 2015
By
Theo Smart
Partners launch phase 2 safety study of a long-acting injectable to prevent HIV

PATH, in collaboration with the US National Institutes of Health (NIH) and the HIV Prevention Trials Network (HPTN), has launched a new study to test the safety and acceptability of a long-acting injectable formulation of the proven antiretroviral drug rilpivirine (TMC278) as a pre-exposure prophylaxis (PrEP) against HIV.

Published
06 March 2015
From
PATH
Are women PrePared?

Can PreP just be provided to men who have sex with men in the UK? What about others? What about other vulnerable populations, such as black women and migrants? What about trans women? All the data we have here in the UK is about men who have sex with men, and this worries me.

Published
02 March 2015
From
Speaking Up! (blog)
Disappointing result for tenofovir-gel microbicide shows that young women still lack HIV prevention methods they can use

Among some highly promising results from HIV prevention studies presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2015) in Seattle, USA, today, there was

Published
25 February 2015
By
Gus Cairns
7-country study shows triple-drug combination superior for preventing infant HIV infection

Implementing the World Health Organization (WHO) recommendation of three-drug antiretroviral treatment during pregnancy leads to a significantly lower rate of mother-to-child HIV transmission, a 7-country randomised study has

Published
25 February 2015
By
Keith Alcorn
VOICE trial: Microbicide gel may have stopped two out of three HIV infections – in the women who used it

The final published paper on the VOICE trial in women in three African countries mainly reinforces what conference presentations have already shown: this ambitious trial failed to

Published
09 February 2015
By
Gus Cairns
Failed Trial in Africa Raises Questions About How to Test HIV Drugs

The failure of the VOICE trial of H.I.V.-prevention methods in Africa — and the elaborate deceptions employed by the women in it — have opened an ethical debate about how to run such studies in poor countries and have already changed the design of some that are now underway.

Published
05 February 2015
From
New York Times
Uganda: High Hopes Ahead of Microbicide Trial Results

HIV/Aids researchers are anticipating positive results from a large-scale trial assessing the efficacy of a vaginal microbicide gel in preventing HIV infection in women.

Published
21 January 2015
From
AllAfrica.com
Improved school attendance credited with reducing HIV infections among teenage girls in Uganda

The Ugandan government’s decision to abolish tuition fees for school pupils, the resulting improved participation in education and an associated decline in adolescent sexual activity are responsible

Published
14 January 2015
By
Roger Pebody
PrEP works in women using injectable hormonal contraceptives and in their male sex partners

Preexposure prophylaxis (PrEP) with tenofovir or tenofovir/emtricitabine proved as effective in women using the injectable hormonal contraceptive depot medroxyprogesterone acetate (DMPA) as in women using no hormonal contraceptive. The same proved true of men whose female sex partners were using DMPA.

Published
07 January 2015
From
International AIDS Society
← First12345...37Next →

Filter by country